INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS

被引：142

作者：

BAUER, LA ^{[1
]}

EDWARDS, WAD ^{[1
]}

DELLINGER, EP ^{[1
]}

SIMONOWITZ, DA ^{[1
]}

机构：

[1] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 24卷 / 05期

关键词：

D O I：

10.1007/BF00542215

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：643 / 647

页数：5

共 22 条

[1] OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION
ABERNETHY, DR
DIVOLL, M
GREENBLATT, DJ
AMEER, B
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) : 783 - 790
[2] ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[3] DIGOXIN DISPOSITION IN OBESITY - CLINICAL PHARMACOKINETIC INVESTIGATION
ABERNETHY, DR
GREENBLATT, DJ
SMITH, TW
[J]. AMERICAN HEART JOURNAL, 1981, 102 (04) : 740 - 744
[4] PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN
BARZA, M
BROWN, RB
SHEN, D
GIBALDI, M
WEINSTEIN, L
[J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) : 165 - 174
[5] AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
BAUER, LA
BLOUIN, RA
GRIFFEN, WO
RECORD, KE
BELL, RM
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04): : 519 - 522
[6] TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
BLOUIN, RA
MANN, HJ
GRIFFEN, WO
BAUER, LA
RECORD, KE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 508 - 512
[7] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS
BLOUIN, RA
BAUER, LA
MILLER, DD
RECORD, KE
GRIFFEN, WO
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 575 - 580
[8] THEOPHYLLINE CLEARANCE - EFFECT OF MARKED OBESITY
BLOUIN, RA
ELGERT, JF
BAUER, LA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) : 619 - 623
[9] GENTAMICIN THERAPY
DEVINE, BJ
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11): : 650 - 655
[10] ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS
DIONNE, RE
BAUER, LA
GIBSON, GA
GRIFFEN, WO
BLOUIN, RA
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06): : 841 - 844

← 1 2 3 →